OBJECTIVE: Pediatric dystonic storm is an underrecognized entity. We aimed to evaluate the profiles of children presenting with dystonic storm in a referral hospital. Management schema and treatment responsiveness of this uncommonly reported entity were analyzed. METHODS: Retrospective review of all children (up to 18 years) hospitalized with dystonic storm over 39 months in the aforementioned facility. RESULTS: Twenty-three children whose ages ranged from 2 years 2 months to 14 years 4 months years (median: 6 years 11 months) (males: 13, females: 11) presented with dystonic storm. The annual incidence was 0.4 per 1,000 fresh admissions with an event rate of 0.9 per 1,000 for all admissions. All had Dystonia Severity Action Plan grades 4/5 with identifiable trigger in 13 (50%). Underlying dystonic disorder preexisted in 10 (43.4%); 8 of these had cerebral palsy. Polypharmacotherapy with >4 drugs out of trihexyphenidyl, tetrabenazine, clonazepam, gabapentin, levodopa-carbidopa, trichlorophos, and melatonin was needed. Supportive care and adequate sedation helped in symptom control. All children were managed with midazolam infusion over 2-10 days (median: 5 days). Mechanical ventilation was resorted to in 6 children (3-22 days). Vecuronium and propofol were used in 3/23 (13%) and 4/23 (17%) children, respectively. Deep brain stimulation was curative in 1 child. Hospitalization ranged from 5 to 31 (median: 11) days. Although there were no deaths, rhabdomyolysis was noted in 1 child. Postdischarge, 6 (26%) children relapsed. CONCLUSIONS: Dystonic storm is a medical emergency mandating aggressive multimodal management. Supportive care, antidystonic drugs, and early elective ventilation alongside adequate sedation with benzodiazepines ameliorate complications. Relapses of dystonic storm are not uncommon.
OBJECTIVE: Pediatric dystonic storm is an underrecognized entity. We aimed to evaluate the profiles of children presenting with dystonic storm in a referral hospital. Management schema and treatment responsiveness of this uncommonly reported entity were analyzed. METHODS: Retrospective review of all children (up to 18 years) hospitalized with dystonic storm over 39 months in the aforementioned facility. RESULTS: Twenty-three children whose ages ranged from 2 years 2 months to 14 years 4 months years (median: 6 years 11 months) (males: 13, females: 11) presented with dystonic storm. The annual incidence was 0.4 per 1,000 fresh admissions with an event rate of 0.9 per 1,000 for all admissions. All had Dystonia Severity Action Plan grades 4/5 with identifiable trigger in 13 (50%). Underlying dystonic disorder preexisted in 10 (43.4%); 8 of these had cerebral palsy. Polypharmacotherapy with >4 drugs out of trihexyphenidyl, tetrabenazine, clonazepam, gabapentin, levodopa-carbidopa, trichlorophos, and melatonin was needed. Supportive care and adequate sedation helped in symptom control. All children were managed with midazolam infusion over 2-10 days (median: 5 days). Mechanical ventilation was resorted to in 6 children (3-22 days). Vecuronium and propofol were used in 3/23 (13%) and 4/23 (17%) children, respectively. Deep brain stimulation was curative in 1 child. Hospitalization ranged from 5 to 31 (median: 11) days. Although there were no deaths, rhabdomyolysis was noted in 1 child. Postdischarge, 6 (26%) children relapsed. CONCLUSIONS: Dystonic storm is a medical emergency mandating aggressive multimodal management. Supportive care, antidystonic drugs, and early elective ventilation alongside adequate sedation with benzodiazepines ameliorate complications. Relapses of dystonic storm are not uncommon.
Authors: Deki Tsering; Laura Tochen; Bennett Lavenstein; Srijaya K Reddy; Yael Granader; Robert F Keating; Chima O Oluigbo Journal: Childs Nerv Syst Date: 2017-02-28 Impact factor: 1.475
Authors: Elisabeth Hertenstein; Nicole K Y Tang; Celia J Bernstein; Christoph Nissen; Martin R Underwood; Harbinder K Sandhu Journal: Sleep Med Rev Date: 2015-05-09 Impact factor: 11.609
Authors: Joseph R Keen; Allison Przekop; Joffre E Olaya; Alexander Zouros; Frank P K Hsu Journal: J Neurosurg Pediatr Date: 2014-10-17 Impact factor: 2.375
Authors: Paolo Mariotti; Alfonso Fasano; M Fiorella Contarino; Giacomo Della Marca; Marco Piastra; Orazio Genovese; Silvia Pulitanò; Antonio Chiaretti; Anna Rita Bentivoglio Journal: Mov Disord Date: 2007-05-15 Impact factor: 10.338